Literature DB >> 23077833

Clinical features of Acanthamoeba keratitis in contact lens wearers and non-wearers.

Darawan Wanachiwanawin1, Wipawee Booranapong, Panida Kosrirukvongs.   

Abstract

Clinical presentations of patients with Acanthamoeba keratitis (AK) attending the Faculty of Medicine Siriraj Hospital during 1996-2006 were reviewed. The studied parameters included history of ocular trauma, use of contact lenses, associated eye diseases, systemic diseases, visual acuity, symptoms, signs, treatment, visual outcomes, and sequelae. Data were analyzed by comparing non-contact lens (nCL) and contact lens (CL) wearers with eachother. Twenty-two patients (24 affected eyes) (68.2% female) had AK, 9 (37.5%) were nCL and 15 (62.5%) were CL. Both groups had similar basic characteristics; however the nCL group was significantly older (48.3 +/- 14.5 vs 30.6 +/- 15.3 years old, p=0.006), and tended to have a longer duration of symptoms with more severe clinical findings, but this was not statistically significant. Eleven had severe ciliary injection (nCL 55.5%, CL 40.0%), 3 had satellite lesions (nCL 22.2%, CL 6.7%), 2 had radial keratoneuritis in the CL group (13.3%), 1 ring infillrate in the nCL group (11.1%) and 1 pseudodendrite in the CL group (6.7%). The mean duration of follow-up was 8.2 +/- 7.9 (ranging 0.3-29) months. Therapeutic measures included anti-Acanthamoeba medications (5/9 for nCL, 8/15 for CL), penetrating keratoplasty due to uncontrolled infections (1/9 for nCL, 2/15 for CL) and corneal perforation (1/9 for nCL), and enucleation due to endophthalmitis (1/9 for CL). At the last follow-up visit, the CL [corrected] group had slightly better visual acuity (55.5% vs 66.7%). In conclusion, AK among patients who do not use contact lenses may have a delayed diagnosis, resulted in more severe ocular manifestations and poorer prognosis. Physicians should be aware of Acanthamoeba infection as a cause of keratitis in any patient, not just contact lens wearers. Long periods of follow-up are recommended to observe for recurrent episodes and proper management of AK patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23077833

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  10 in total

1.  Isolation and identification of Acanthamoeba species from natural water sources in the northeastern part of Thailand.

Authors:  Thani Thammaratana; Porntip Laummaunwai; Thidarut Boonmars
Journal:  Parasitol Res       Date:  2016-01-16       Impact factor: 2.289

2.  Acanthamoeba DNA can be directly amplified from corneal scrapings.

Authors:  Nagwa Mostafa El-Sayed; Mohamed Saad Younis; Azza Mohamed Elhamshary; Amina Ibrahim Abd-Elmaboud; Shereen Magdy Kishik
Journal:  Parasitol Res       Date:  2014-06-21       Impact factor: 2.289

3.  IL-17A-mediated protection against Acanthamoeba keratitis.

Authors:  Amol Suryawanshi; Zhiyi Cao; James F Sampson; Noorjahan Panjwani
Journal:  J Immunol       Date:  2014-12-10       Impact factor: 5.422

4.  Failure of chemotherapy in the first reported cases of Acanthamoeba keratitis in Pakistan.

Authors:  Ruqaiyyah Siddiqui; Tanveer Chaudhry; Sahreena Lakhundi; Khabir Ahmad; Naveed Ahmed Khan
Journal:  Pathog Glob Health       Date:  2013-12-27       Impact factor: 2.894

5.  Artemisia annua L. as a plant with potential use in the treatment of acanthamoebiasis.

Authors:  Monika Derda; Edward Hadaś; Marcin Cholewiński; Łukasz Skrzypczak; Anna Grzondziel; Agnieszka Wojtkowiak-Giera
Journal:  Parasitol Res       Date:  2016-01-19       Impact factor: 2.289

6.  Amoebicidal Activity of Poly-Epsilon-Lysine Functionalized Hydrogels.

Authors:  Stephnie M Kennedy; Pallavi Deshpande; Andrew G Gallagher; Malcolm J Horsburgh; Heather E Allison; Stephen B Kaye; Donald A Wellings; Rachel L Williams
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

7.  Amoebicidal and Amoebistatic Effects of Artemisia argyi Methanolic Extracts on Acanthamoeba castellanii Trophozoites and Cysts.

Authors:  Onur Kolören; Zeynep Kolören; Zülal Atli Şekeroğlu; Melek Çolayvaz; Panagiotis Karanis
Journal:  Acta Parasitol       Date:  2019-01-28       Impact factor: 1.440

8.  Evaluating the in vitro efficacy of gatifloxacin, levofloxacin and gentamicin against Acanthamoeba cysts.

Authors:  Thaksaporn Thongseesuksai; Phanthipha Wongwai; Thidarut Boonmars; Oranuch Sanpool; Porntip Laummaunwai
Journal:  Int Ophthalmol       Date:  2019-10-05       Impact factor: 2.031

9.  Potentially pathogenic free-living amoebae in some flood-affected areas during 2011 Chiang Mai flood.

Authors:  Anchalee Wannasan; Pichart Uparanukraw; Apichart Songsangchun; Nimit Morakote
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2013 Nov-Dec       Impact factor: 1.846

10.  Comparative in vitro effectiveness of a novel contact lens multipurpose solution on Acanthamoeba castellanii.

Authors:  Alyssa C Fears; Rebecca C Metzinger; Stephanie Z Killeen; Robert S Reimers; Chad J Roy
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-10-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.